Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma
Abstract
No abstract.
Paper Details
Title
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma
Published Date
Oct 1, 2021
Volume
10
Issue
5
Pages
737 - 740
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History